NCT05180110View on ClinicalTrials.gov

A Performance Evaluation of the LumiraDx Point of Care CRP Assay

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

January 11, 2022

Study Completion Date

May 30, 2023

Conditions
InflammationInfectionsTissue Injury
Interventions
DIAGNOSTIC_TEST

Venepuncture

Venous blood draw

DIAGNOSTIC_TEST

Fingerstick

Capillary blood draw

Trial Locations (3)

Unknown

Royal Infirmary Edinburgh, Edinburgh

St Georges Hospital, London

University College London Hospital, London

All Listed Sponsors
lead

LumiraDx UK Limited

INDUSTRY

NCT05180110 - A Performance Evaluation of the LumiraDx Point of Care CRP Assay | Biotech Hunter | Biotech Hunter